Publication:
Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia

dc.contributor.authorLiang Kung Chenen_US
dc.contributor.authorLi Kuo Liuen_US
dc.contributor.authorJean Wooen_US
dc.contributor.authorPrasert Assantachaien_US
dc.contributor.authorTung Wai Auyeungen_US
dc.contributor.authorKamaruzzaman Shahrul Bahyahen_US
dc.contributor.authorMing Yueh Chouen_US
dc.contributor.authorLiang Yu Chenen_US
dc.contributor.authorPi Shan Hsuen_US
dc.contributor.authorOrapitchaya Krairiten_US
dc.contributor.authorJenny S.W. Leeen_US
dc.contributor.authorWei Ju Leeen_US
dc.contributor.authorYunhwan Leeen_US
dc.contributor.authorChih Kuang Liangen_US
dc.contributor.authorPanita Limpawattanaen_US
dc.contributor.authorChu Sheng Linen_US
dc.contributor.authorLi Ning Pengen_US
dc.contributor.authorShosuke Satakeen_US
dc.contributor.authorTakao Suzukien_US
dc.contributor.authorChang Won Wonen_US
dc.contributor.authorChih Hsing Wuen_US
dc.contributor.authorSi Nan Wuen_US
dc.contributor.authorTeimei Zhangen_US
dc.contributor.authorPing Zengen_US
dc.contributor.authorMasahiro Akishitaen_US
dc.contributor.authorHidenori Araien_US
dc.contributor.otherVeterans General Hospital-Taipeien_US
dc.contributor.otherChinese University of Hong Kongen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Malayaen_US
dc.contributor.otherVeterans General Hospital-Kaohsiung Taiwanen_US
dc.contributor.otherTaichung Hospitalen_US
dc.contributor.otherAjou University, School of Medicineen_US
dc.contributor.otherKhon Kaen Universityen_US
dc.contributor.otherVeterans General Hospital-Taichung Taiwanen_US
dc.contributor.otherNational Center for Geriatrics and Gerontology - National Institute for Longevity Sciencesen_US
dc.contributor.otherKyung Hee Universityen_US
dc.contributor.otherNational Cheng Kung University Hospitalen_US
dc.contributor.otherMinistry of Health of People's Republic of Chinaen_US
dc.contributor.otherKyoto University Faculty of Medicineen_US
dc.contributor.otherUniversity of Tokyoen_US
dc.date.accessioned2018-11-09T03:06:45Z
dc.date.available2018-11-09T03:06:45Z
dc.date.issued2014-01-01en_US
dc.description.abstractSarcopenia, a newly recognized geriatric syndrome, is characterized by age-related decline of skeletal muscle plus low muscle strength and/or physical performance. Previous studies have confirmed the association of sarcopenia and adverse health outcomes, such as falls, disability, hospital admission, long term care placement, poorer quality of life, and mortality, which denotes the importance of sarcopenia in the health care for older people. Despite the clinical significance of sarcopenia, the operational definition of sarcopenia and standardized intervention programs are still lacking. It is generally agreed by the different working groups for sarcopenia in the world that sarcopenia should be defined through a combined approach of muscle mass and muscle quality, however, selecting appropriate diagnostic cutoff values for all the measurements in Asian populations is challenging. Asia is a rapidly aging region with a huge population, so the impact of sarcopenia to this region is estimated to be huge as well. Asian Working Group for Sarcopenia (AWGS) aimed to promote sarcopenia research in Asia, and we collected the best available evidences of sarcopenia researches from Asian countries to establish the consensus for sarcopenia diagnosis. AWGS has agreed with the previous reports that sarcopenia should be described as low muscle mass plus low muscle strength and/or low physical performance, and we also recommend outcome indicators for further researches, as well as the conditions that sarcopenia should be assessed. In addition to sarcopenia screening for community-dwelling older people, AWGS recommends sarcopenia assessment in certain clinical conditions and healthcare settings to facilitate implementing sarcopenia in clinical practice. Moreover, we also recommend cutoff values for muscle mass measurements (7.0 kg/m2 for men and 5.4 kg/m2 for women by using dual X-ray absorptiometry, and 7.0 kg/m2 for men and 5.7 kg/m2 for women by using bioimpedance analysis), handgrip strength (<26 kg for men and <18 kg for women), and usual gait speed (<0.8 m/s). However, a number of challenges remained to be solved in the future. Asia is made up of a great number of ethnicities. The majority of currently available studies have been published from eastern Asia, therefore, more studies of sarcopenia in south, southeastern, and western Asia should be promoted. On the other hand, most Asian studies have been conducted in a cross-sectional design and few longitudinal studies have not necessarily collected the commonly used outcome indicators as other reports from Western countries. Nevertheless, the AWGS consensus report is believed to promote more Asian sarcopenia research, and most important of all, to focus on sarcopenia intervention studies and the implementation of sarcopenia in clinical practice to improve health care outcomes of older people in the communities and the healthcare settings in Asia. © 2014 American Medical Directors Association, Inc.en_US
dc.identifier.citationJournal of the American Medical Directors Association. Vol.15, No.2 (2014), 95-101en_US
dc.identifier.doi10.1016/j.jamda.2013.11.025en_US
dc.identifier.issn15389375en_US
dc.identifier.issn15258610en_US
dc.identifier.other2-s2.0-84892967799en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34879
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84892967799&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectNursingen_US
dc.titleSarcopenia in Asia: Consensus report of the Asian working group for sarcopeniaen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84892967799&origin=inwarden_US

Files

Collections